Onconetix BWV Stock
Onconetix Price Chart
Onconetix BWV Financial and Trading Overview
| Onconetix stock price | 0.18 USD |
| Previous Close | 1.28 USD |
| Open | 1.18 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 3200 |
| Day's Range | 1.12 - 1.25 USD |
| 52 Week Range | 0.73 - 8 USD |
| Volume | 2.2M USD |
| Avg. Volume | 1.05M USD |
| Market Cap | 19.09M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.5 USD |
BWV Valuation Measures
| Enterprise Value | 103.53K USD |
| Trailing P/E | N/A |
| Forward P/E | -2.8571432 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.96774197 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.007 |
Trading Information
Onconetix Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -51.21% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8 USD |
| 52 Week Low | 0.73 USD |
| 50-Day Moving Average | 0.98 USD |
| 200-Day Moving Average | 1.3 USD |
BWV Share Statistics
| Avg. Volume (3 month) | 1.05M USD |
| Avg. Daily Volume (10-Days) | 6.03M USD |
| Shares Outstanding | 15.91M |
| Float | 10.84M |
| Short Ratio | 2.21 |
| % Held by Insiders | 25.38% |
| % Held by Institutions | 17.24% |
| Shares Short | 209.18K |
| Short % of Float | 1.95% |
| Short % of Shares Outstanding | 1.32% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -43.49% |
| Return on Equity (ttm) | -78.37% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -14551688 USD |
| Net Income Avi to Common (ttm) | -14195813 USD |
| Diluted EPS (ttm) | -1.52 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 20.26M USD |
| Total Cash Per Share (mrq) | 1.27 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 8.001 |
| Book Value Per Share (mrq) | 1.24 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12258852 USD |
| Levered Free Cash Flow (ttm) | -8672894 USD |
Profile of Onconetix
| Country | United States |
| State | OH |
| City | Cincinnati |
| Address | 201 East Fifth Street |
| ZIP | 45202 |
| Phone | 513 620 4101 |
| Website | https://www.bluewatervaccines.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also develops other products that are under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. Blue Water Vaccines, Inc. was incorporated in 2018 and is based in Cincinnati, Ohio.
Q&A For Onconetix Stock
What is a current BWV stock price?
Onconetix BWV stock price today per share is 0.18 USD.
How to purchase Onconetix stock?
You can buy BWV shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Onconetix?
The stock symbol or ticker of Onconetix is BWV.
Which industry does the Onconetix company belong to?
The Onconetix industry is Biotechnology.
How many shares does Onconetix have in circulation?
The max supply of Onconetix shares is 18.9M.
What is Onconetix Price to Earnings Ratio (PE Ratio)?
Onconetix PE Ratio is 0.00000000 now.
What was Onconetix earnings per share over the trailing 12 months (TTM)?
Onconetix EPS is 0 USD over the trailing 12 months.
Which sector does the Onconetix company belong to?
The Onconetix sector is Healthcare.
Onconetix BWV included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16920.58 USD — |
-0.58
|
6.33B USD — | 16873.97 USD — | 16989.6 USD — | — - | 6.33B USD — |
| NASDAQ HealthCare IXHC | 967.78 USD — |
-1.12
|
— — | 964.91 USD — | 969.79 USD — | — - | — — |
- {{ link.label }} {{link}}